Senior Application Developer (AWS, C#) - Remote
Revvity, Inc.over 1 year ago
Remote, CanadaSenior
Responsibilities
- Build and deliver complex event-based, distributed software products.
- Develop cloud-native SaaS product features using C# .NET and AWS services.
- Implement messaging-based systems, with RabbitMQ preferred.
- Collaborate with UX/UI designers, DevOps, and fellow engineers in small Agile/Scrum teams.
- Integrate third-party security authentication services and support application monitoring.
- Explain complex technical topics clearly and contribute creative problem-solving.
Requirements
- At least 6 years of experience building and delivering event-based, distributed software products.
- At least 3 years of experience building SaaS products in an AWS cloud environment.
- Proficiency with AWS web services including ECS, S3, EventBridge, Lambda, Step Functions, Route 53, RDS PostgreSQL, DynamoDB, DocumentDB, and Glue.
- Proficiency with C# and .NET 8.
- Experience with messaging systems; RabbitMQ is preferred.
- Experience working in an Agile/Scrum environment.
- Bachelor’s degree in Computer Science, Computer Engineering, or equivalent.
- Experience integrating third-party security authentication services, with Auth0 a plus.
- Experience building generative AI features and using Amazon Bedrock is a plus.
- Experience with IDE security plug-ins such as Snyk.
- Experience with application monitoring platforms such as Instana, New Relic, or Datadog is preferred.
- Clinical, bioinformatics, or other health sciences experience is advantageous.
- Strong verbal and written communication, collaborative problem-solving, and willingness to learn are required.
Benefits
- Remote role based in Ontario, Canada.
About Revvity, Inc.
Revvity builds instruments, reagents, assays, and informatics software for life-science research and clinical diagnostics, serving pharma/biotech companies, diagnostic labs, academia, and governments. Formed in 2023 from PerkinElmer’s life sciences and diagnostics businesses, it is headquartered in Waltham, Massachusetts and listed on the NYSE (RVTY). The company’s portfolio spans multi-omics, imaging, screening, detection, and services, including brands such as BioLegend for research reagents.